Free Trial
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

Carl Zeiss Meditec logo
€34.44 +0.04 (+0.12%)
As of 11/12/2026

About Carl Zeiss Meditec Stock (ETR:AFX)

Advanced

Key Stats

Today's Range
€34.08
▼
€35.02
50-Day Range
€29.02
▼
€35.80
52-Week Range
€54.60
▼
€123.75
Volume
92,980 shs
Average Volume
94,405 shs
Market Capitalization
€3.21 billion
P/E Ratio
18.41
Dividend Yield
1.60%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFX Stock News Headlines

Carl Zeiss Meditec AG 1AFX
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
New Carl Zeiss Meditec chief to start in 2026
See More Headlines

AFX Stock Analysis - Frequently Asked Questions

Carl Zeiss Meditec's stock was trading at €40.00 on January 1st, 2026. Since then, AFX stock has decreased by 13.9% and is now trading at €34.44.

Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Volkswagen (VOW3), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Chevron (CVX), Merck & Co., Inc. (MRK) and Pfizer (PFE).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
ETR:AFX
CIK
N/A
Fax
N/A
Employees
4,950
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
€1.87
Trailing P/E Ratio
18.41
Forward P/E Ratio
N/A
P/E Growth
2.83
Net Income
€185.59 million
Net Margins
4.40%
Pretax Margin
N/A
Return on Equity
5.52%
Return on Assets
7.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
2.47

Sales & Book Value

Annual Sales
€2.69 billion
Price / Sales
1.19
Cash Flow
€0.02 per share
Price / Cash Flow
1,398.28
Book Value
€24.43 per share
Price / Book
1.41

Miscellaneous

Outstanding Shares
93,178,085
Free Float
N/A
Market Cap
€3.21 billion
Optionable
Not Optionable
Beta
1.33
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (ETR:AFX) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners